Lopinavir And Ritonavir Tablet, Film Coated
Product Images NDC 33342-163

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lopinavir And Ritonavir (NDC 33342-163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

288 (Formula)

An illustration showing the formula to calculate Body Surface Area (BSA) in square meters. The formula is BSA = the square root of (height in centimeters multiplied by weight in kilograms, divided by 3600).*

FDA Label Image

534 (Lopinavir Ritonavir 100 25 60s Count)

Label for Lopinavir and Ritonavir Tablets, USP 100 mg / 25 mg by Macleods Pharmaceuticals Limited. The film-coated tablet container includes 60 tablets and provides warnings about medicines not to take with this product. The label includes storage instructions and pharmacist dispensing information, along with the NDC 33342-163-09 and manufacturing details for Macleods Pharma USA, Inc.*

FDA Label Image

564 (Lopinavir Ritonavir 200 50 120s Count)

Label for Lopinavir and Ritonavir Tablets, USP 200 mg / 50 mg film-coated tablets. Displayed are active ingredients strengths, pharmacist instructions including a warning not to cover the ALERT box, storage conditions, and packaging in a 120 tablet bottle. The label includes Macleods Pharma USA and Macleods Pharmaceuticals Ltd as manufacturers, national drug code, and barcodes.*

FDA Label Image

Str-lopi (Lopinavir Ritonavir Str Lopi)

Chemical structure of the active ingredients Lopinavir and Ritonavir depicted as a molecular diagram showing atoms and bonds representing their chemical composition.*

FDA Label Image

Str-rito (Lopinavir Ritonavir Str Rito)

Chemical structure diagram of Lopinavir and Ritonavir, showing the molecular configuration of the combined active ingredients. The schematic includes ring structures and various functional groups characteristic of these antiviral agents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.